Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

| More on:
A happy young couple lie on a wooden deck using a skateboard for a pillow.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With most brokers taking a break over the holiday period, there haven't been many notes hitting the wires.

But never fear! Summarised below are three recent recommendations that remain very relevant today. Here's what brokers are saying about these ASX shares:

Boss Energy Ltd (ASX: BOE)

According to a note out of Bell Potter, its analysts retained their buy rating on this uranium producer's shares with a reduced price target of $4.70. The broker acknowledges that Boss Energy is one of the most shorted shares on the Australian share market. And while it expects the company's costs to come in ahead of expectations, it doesn't believe it will be as bad as short sellers are forecasting. As a result, it thinks short sellers run the risk of being squeezed. So, with its shares screening as incredibly cheap against North American peers, Bell Potter suspects that its shares could re-rate significantly if things go to plan. The Boss Energy share price ended the week at $2.61.

CSL Ltd (ASX: CSL)

A note out of UBS revealed that its analysts retained their buy rating on this biotechnology company's shares with a trimmed price target of $330.00. According to the note, the broker has reduced its earnings estimates and valuation to reflect its belief that trading conditions are not as favourable as hoped for CSL's vaccines business. However, the broker remains bullish on CSL. This is due to the positive outlook for its key CSL Behring plasma business. UBS feels that consensus estimates are achievable, and solid earnings growth is on the way thanks partly to expanding margins. The CSL share price was fetching $283.43 at Friday's close.

Pro Medicus Limited (ASX: PME)

Analysts at Morgan Stanley initiated coverage on this health imaging technology company's shares with an overweight rating and $300.00 price target. According to the note, the broker believes that Pro Medicus has similar qualities to logistics software developer WiseTech Global Ltd (ASX: WTC). Like WiseTech's solutions, Morgan Stanley highlights that Pro Medicus' solutions are very scalable and have relatively low penetration of global markets and low customer churn rates. Morgan Stanley believes this positions Pro Medicus to grow its customer volumes quicker than the industry over the next five years. It is expecting customer volume growth of roughly 7% per annum, whereas it expects the industry to grow at a much lower rate of 2.3% per annum. The Pro Medicus share price was trading at $253.39 on Friday.

Should you invest $1,000 in Hastings Technology Metals Limited right now?

Before you buy Hastings Technology Metals Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Hastings Technology Metals Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has positions in CSL, Pro Medicus, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended WiseTech Global. The Motley Fool Australia has recommended CSL and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man pointing at a blue rising share price graph.
Technology Shares

Up 30% in a month, this ASX 200 tech share is 'a compelling opportunity': expert

Analysts from listed investment company WAM Capital say this ASX 200 tech stock is worth watching.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

View of a mine site.
Broker Notes

How much upside does Macquarie tip for Deterra Royalties shares?

Deterra Royalties offers ASX investors a different way to invest in global mining.

Read more »

Woman with $50 notes in her hand thinking, symbolising dividends.
Broker Notes

Broker reveals outlook for ASX dividend shares amid volatile market

Peter Gardner from Plato Investment Management tells ASX investors where to look for dividend income this year.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker puts buy rating on Zip shares

Big returns could be on offer for investors according to its analysts.

Read more »

gaming asx share price rise represented by slot machine paying jackpot
Broker Notes

What does Macquarie expect from Aristocrat Leisure shares when it reports on 14 May?

Here's what the broker is expecting from this gaming technology company next week.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Goldman Sachs says these ASX 200 stocks are strong buys

The broker is feeling very bullish about these stocks. But why?

Read more »